HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N(epsilon)-(carboxymethyl)hydroxylysine

structure given in first source

Also Known As:

CMhL

Networked: 10 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675

Experts

1.	Roth, Christian L: 3 articles (01/2017 - 03/2011)
2.	Elfers, Clinton: 2 articles (02/2016 - 03/2011)
3.	Anschuetz, Lukas: 1 article (10/2019)
4.	Caversaccio, Marco: 1 article (10/2019)
5.	Kompis, Martin: 1 article (10/2019)
6.	Mantokoudis, Georgios: 1 article (10/2019)
7.	Wimmer, Wilhelm: 1 article (10/2019)
8.	von Werdt, Moritz: 1 article (10/2019)
9.	Dalir-Naghadeh, Bahram: 1 article (04/2019)
10.	Ehteshamfar, Shahin: 1 article (04/2019)

Related Diseases

1.	Infections 07/01/2016 - "Knowing that CMhl infections can lead to severe disease resulting in death if combined with other diseases or stress, it was the aim of this study to assess prevalence data from camelids in Austria. " 07/01/2016 - "Reports of CMhl infections in South American Camelids in Europe are only available from the United Kingdom and Switzerland. " 09/01/2009 - "Oxytetracyline administration did not consistently clear CMhl infection. " 09/01/2009 - "To develop a PCR assay for Candidatus Mycoplasma haemolamae (CMhl) infection in alpacas and use it to study the efficacy of oxytetracycline treatment and development of a subclinical carrier state. "
2.	Mixed Conductive-Sensorineural Hearing Loss 10/01/2019 - "We assessed the outcome of 28 subjects with either conductive or mixed hearing loss (CMHL) or single-sided deafness (SSD) who were undergoing a Bonebridge implantation. " 10/01/2015 - "The BAHA Divino and BP100 sound processors were applied in 12 patients with conductive/mixed hearing loss (CMHL) and in 10 subjects with single sided deafness (SSD). "
3.	Weight Gain 01/01/2017 - "In CMHL rats (age 3 months), postsurgery excess weight gain was significantly inhibited (ZGN-440, 0.2 ± 0.7 g/d; vehicle, 3.8 ± 0.6 g/d; P < 0.001) during 12 days of ZGN-440 treatment (0.1 mg/kg daily subcutaneously) together with a 30% reduction of daily food intake vs vehicle injection. " 01/01/2011 - "Specifically, we used a novel electrolytically generated combined medial hypothalamic lesion (CMHL) affecting the arcuate nucleus, ventromedial hypothalamic nucleus, and dorsomedial hypothalamic nucleus to induce hyperphagia, rapid weight gain, and adiposity. "
4.	Obesity 03/01/2011 - "Therefore, the CMHL model best mimics the complex metabolic abnormalities observed in obese CP patients compared with lesions to other hypothalamic areas and provides a foundation for future pharmacological approaches to treat obesity in children with hypothalamic damage." 03/01/2011 - "Only the CMHL model exhibited all key features observed in patients with hypothalamic obesity induced by CP. " 01/01/2017 - "We tested the methionine aminopeptidase 2-inhibitor beloranib (ZGN-440) in 2 male rat models of obesity, one modeling hypothalamic obesity with a combined medial hypothalamic lesion (CMHL) and the other modeling a monogenic form of obesity with MC4r mutations (MC4r knockout [MC4rKO]). "
5.	Deafness (Deaf Mutism) 10/01/2019 - "We assessed the outcome of 28 subjects with either conductive or mixed hearing loss (CMHL) or single-sided deafness (SSD) who were undergoing a Bonebridge implantation. " 10/01/2015 - "The BAHA Divino and BP100 sound processors were applied in 12 patients with conductive/mixed hearing loss (CMHL) and in 10 subjects with single sided deafness (SSD). "

Related Drugs and Biologics

1.	Oxytetracycline (Terramycin)
2.	Silver Sulfadiazine (SSD)
3.	Sodium Glutamate (Accent)
4.	Messenger RNA (mRNA)
5.	Oxytocin (Pitocin)
6.	Methionine (L-Methionine)
7.	Aminopeptidases
8.	CKD732